ARS Pharmaceuticals Raises $55M in Series D Funding - FinSMEs

By FinSMEs. -. August 31, 2021. ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding. The round was led by SR One with participation …


Install CouponFollow Chrome Extension   CouponFollow Extension

$55
OFF

ARS Pharmaceuticals Raises $55M In Series D Funding - FinSMEs

6 days from now

By FinSMEs. -. August 31, 2021. ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding. The round was led by SR One with participation …

finsmes.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding For …

6 days from now

San Diego, Calif. – August 31, 2021 – ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from …

ars-pharma.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding For …

6 days from now

Aug 31, 2021  · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) ... has closed on a Series D financing of $55 …

prnewswire.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding For …

6 days from now

Aug 31, 2021  · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) PRESS RELEASE PR Newswire Aug. 31, …

businessinsider.com

$55
OFF

ARS Pharma Raises $55M - San Diego Business Journal

6 days from now

Sep 12, 2021  · ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an …

sdbj.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding - San …

6 days from now

ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal …

pressreader.com

$75
OFF

ARS Pharmaceuticals - Raised $75M Funding From 5 Investors

6 days from now

Oct 30, 2024  · List of ARS Pharmaceuticals's institutional investors. SR One, located in Redwood City (United States), made their first investment in ARS Pharmaceuticals on Aug 31, 2021 in …

tracxn.com

$465
OFF

ARS Scores Deal Worth Up To $465M - San Diego Business Journal …

6 days from now

21 hours ago  · Launched in 2015, Carmel Valley-based ARS has received $315 million in funding. In 2021, it raised $55 million in Series D funding in preparation for the launch of its lead …

sdbj.com

$55
OFF

ARS Pharmaceuticals Snags $55M In Series D Funding

6 days from now

Tuesday, August 31, 2021 ARS Pharmaceuticals Snags $55M In Series D Funding. San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to …

socaltech.com

$55
OFF

Wilson Sonsini Advises SR One On ARS Pharmaceuticals’ $55 …

6 days from now

Sep 8, 2021  · On August 31, 2021, ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from …

wsgr.com

$55
OFF

Series D - ARS Pharmaceuticals - 2021-08-31 - Crunchbase

6 days from now

Aug 31, 2021  · FinSMEs — ARS Pharmaceuticals Raises $55M in Series D Funding . News • Aug 31, 2021. ars-pharma.com — ARS Pharmaceuticals Raises $55 Million in Series D Funding …

crunchbase.com

$55
OFF

Firm Advises ARS Pharmaceuticals On IP Matters Related To $55 …

6 days from now

Wilson Sonsini Goodrich & Rosati advises ARS Pharmaceuticals on all IP matters and represented the company in IP matters related to the transaction. “This additional funding will …

wsgr.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding

6 days from now

Aug 31, 2021  · ARS Pharmaceuticals, Inc. has closed on a Series D financing of $55 million led by SR One with participation from RA Capital Management, and one other U.S.-based, …

biospace.com

$55
OFF

Ars Pharmaceuticals, Inc. Raises $55m In Venture Funding

6 days from now

ARS Pharma Raises $55M. ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product …

selligence.com

$55
OFF

ARS Pharmaceuticals, Inc. – Funding, Valuation, Investors, News

6 days from now

Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. ... Funding Rounds 1. ... 14.10.2021: Series D: $55M …

parsers.vc

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding

6 days from now

SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- ARS Pharmaceuticals Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves …

biospace.com

$55
OFF

ARS Pharmaceuticals Raises $55 Million In Series D Funding For …

6 days from now

Sep 2, 2021  · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) Home » ARS Pharmaceuticals Raises $55 …

redpeppermergers.com

$55
OFF

ARS Pharmaceuticals’ $55 Million Series D Financing

6 days from now

Sep 14, 2021  · ARS Pharmaceuticals’ $55 Million Series D Financing; ARS Pharmaceuticals’ $55 Million Series D Financing. September 14, 2021 Martina Bellini. Tagged: Bridget Balisy Dan …

globallegalchronicle.com

$55
OFF

Augury Raises $55M In Series D Funding - FinSMEs

6 days from now

By FinSMEs. -. October 14, 2020. Augury, a NYC-based AI-based Machine Health solution provider, secured $55m in Series D funding. The round was led by Qumra Capital, with …

finsmes.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension